March 24, 2025

Longer Breastfeeding Duration Linked to Fewer Developmental Delays in Large Study

Children breastfed for 6+ months showed 27% lower odds of developmental delays and neurodevelopmental conditions in comprehensive Israeli analysis of 570,000+ children, with sibling comparisons confirming protective effects.

Conexiant

March 24, 2025

HS Guidelines for Special Populations

"These guidelines address the unique needs of diverse groups typically underrepresented in clinical trials, and highlight the importance of a multidisciplinary approach."

Conexiant

March 20, 2025

FDA Youth E-Cigarette Ad Linked to Lower Initiation

E-cigarette initiation among U.S. youth was reduced following The Real Cost Youth E-cigarette Prevention Campaign.

Conexiant

March 20, 2025

Neurological Soft Signs in PANS Linked to Disease Severity

Neurological soft signs were present in 79.8% of patients with pediatric acute-onset neuropsychiatric syndrome, and severity increased alongside more NSSs.

Conexiant

March 20, 2025

Prenatal Exposure to PFAS in Contaminated Water

Results suggest associations between predicted prenatal maternal PFAS serum concentrations and some childhood cancers

Conexiant

March 18, 2025

The Real Cost Campaign May Have Prevented Thousands of Youths From Initiating E-Cigarette Use

Investigators examined the results of the U.S. Food and Drug Administration's youth e-cigarette prevention campaign, known as The Real Cost.

The ASCO Post

March 18, 2025

High-Risk Rhabdomyosarcoma: Long-Term Outcomes With Maintenance Chemotherapy

Long-term follow-up of the European Paediatric Soft Tissue Sarcoma Study Group RMS2005 trial was recently reported.

The ASCO Post

March 17, 2025

Do Congenital Heart Defects Affect Cancer Risk in Newborns and Their Mothers?

A study published in the American Heart Association's journal Circulation explored whether babies born with a congenital heart defects and their mothers may experience an elevated risk of cancer.   

The ASCO Post

March 14, 2025

HPV Vaccine Reduces Actinic Keratoses

VAXAK randomized trial demonstrates significant reduction in precancerous skin lesions following standard 9-valent alphapapillomavirus vaccination.

Conexiant